APOC3 and metabolic dysfunction-associated steatotic liver disease: To shed light on the interaction between serum lipidomics and NAFLD, we further investigated the association of APOC3 rs2070667-related differential serum lipids and NAFLD-specific pathological disorders (hepatocyte steatosis, lobular inflammation, ballooning, and liver fibrosis).